1. Home
  2. ENTX vs ORMP Comparison

ENTX vs ORMP Comparison

Compare ENTX & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENTX
  • ORMP
  • Stock Information
  • Founded
  • ENTX 2010
  • ORMP 2002
  • Country
  • ENTX Israel
  • ORMP United States
  • Employees
  • ENTX N/A
  • ORMP N/A
  • Industry
  • ENTX Biotechnology: Biological Products (No Diagnostic Substances)
  • ORMP Biotechnology: Pharmaceutical Preparations
  • Sector
  • ENTX Health Care
  • ORMP Health Care
  • Exchange
  • ENTX Nasdaq
  • ORMP Nasdaq
  • Market Cap
  • ENTX 90.2M
  • ORMP 90.7M
  • IPO Year
  • ENTX 2018
  • ORMP N/A
  • Fundamental
  • Price
  • ENTX $2.43
  • ORMP $2.40
  • Analyst Decision
  • ENTX Strong Buy
  • ORMP Hold
  • Analyst Count
  • ENTX 1
  • ORMP 1
  • Target Price
  • ENTX $10.00
  • ORMP N/A
  • AVG Volume (30 Days)
  • ENTX 91.5K
  • ORMP 490.7K
  • Earning Date
  • ENTX 03-07-2025
  • ORMP 03-05-2025
  • Dividend Yield
  • ENTX N/A
  • ORMP N/A
  • EPS Growth
  • ENTX N/A
  • ORMP N/A
  • EPS
  • ENTX N/A
  • ORMP 0.11
  • Revenue
  • ENTX $99,000.00
  • ORMP N/A
  • Revenue This Year
  • ENTX N/A
  • ORMP N/A
  • Revenue Next Year
  • ENTX N/A
  • ORMP N/A
  • P/E Ratio
  • ENTX N/A
  • ORMP $22.11
  • Revenue Growth
  • ENTX 607.14
  • ORMP N/A
  • 52 Week Low
  • ENTX $0.95
  • ORMP $2.00
  • 52 Week High
  • ENTX $3.35
  • ORMP $3.67
  • Technical
  • Relative Strength Index (RSI)
  • ENTX 54.06
  • ORMP 55.14
  • Support Level
  • ENTX $2.21
  • ORMP $2.16
  • Resistance Level
  • ENTX $2.62
  • ORMP $3.09
  • Average True Range (ATR)
  • ENTX 0.21
  • ORMP 0.15
  • MACD
  • ENTX -0.01
  • ORMP 0.03
  • Stochastic Oscillator
  • ENTX 69.35
  • ORMP 28.87

About ENTX Entera Bio Ltd.

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.

About ORMP Oramed Pharmaceuticals Inc.

Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.

Share on Social Networks: